From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 475,816,819 shares, representing 23.94% for $29,984.88 million under the buyback announced on October 27, 2016.
Market Closed -
Other stock markets
|
Pre-market 09:22:49 | |||
41.12 USD | +2.17% | 41.3 | +0.41% |
02:58pm | Bristol Myers: presents advances in lung cancer | CF |
06-02 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.85% | 83.29B | |
+40.73% | 739B | |
+31.77% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.42% | 240B | |
+9.45% | 210B | |
-5.44% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on October 27, 2016.